The roll-out of insulin biosimilars could inform policy to improve the upcoming launch of Humira biosimilars, new Biosimilars Council Executive Director Craig Burton said. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
